Key result
Perioperative management of antiplatelet therapy in ophthalmic surgery requires balancing the risks of hemorrhagic complications against thromboembolic events based on surgery type and comorbidities.
Why the study?
In patients undergoing ophthalmic surgery on antiplatelet therapy, the risk of perioperative hemorrhagic complications must be weighed against thromboembolic risks associated with therapy cessation.
This review provides evidence-based recommendations for balancing the risks of bleeding and thrombosis when managing antiplatelet therapy in patients undergoing ophthalmic surgery.
Answers are grounded in this paper and cite their sources.
Case-by-case antiplatelet decisions remain essential in ophthalmic surgery; leaves open need for prospective trials to standardize protocols.
Many patients undergoing ophthalmic surgery are elderly with comorbidities requiring antiplatelet therapy to prevent thromboembolic or atherothrombotic events. The use of antiplatelet therapy has expanded over the years, predisposing these patients to hemorrhagic complications perioperatively. The risk of hemorrhagic complications must be weighed against the risk of thromboembolic events with cessation of antiplatelet therapy. The decision to continue or interrupt antiplatelet therapy in the setting of ophthalmic surgery is based upon various factors, including the type of surgery and each patient’s comorbidities. This review examines the risks of thrombotic complications versus hemorrhagic complications in different types of ophthalmic surgeries with the use of antiplatelet medications and provides evidence-based recommendations regarding perioperative management of antiplatelet therapy
No takes yet. Share an insight, caveat, or question.
Idrees et al. (2020) conducted a review in Ophthalmic surgery requiring antiplatelet therapy. Perioperative management of antiplatelet therapy was evaluated. Perioperative management of antiplatelet therapy in ophthalmic surgery requires balancing the risks of hemorrhagic complications against thromboembolic events based on surgery type and comorbidities.
Synapse has enriched 10 related papers. Consider them for comparative context: